National Academies advisory: Meeting on therapeutic vaccines

March 25, 2004

National Academy of Sciences
April 1-3

Medical research is increasingly trying to broaden the definition and mission of vaccines, seeking to develop not only substances that can prevent illness but also vaccines to treat those already suffering from AIDS, hepatitis, and other diseases. This meeting, part of the National Academy of Sciences' Arthur M. Sackler colloquium series, will bring together medical researchers, immunologists, biologists, and cancer specialists to discuss developments in the field.

ANTHONY FAUCI, director of the National Institute of Allergy and Infectious Diseases, will deliver the KEYNOTE ADDRESS AT 6 P.M. ON APRIL 1.

The meeting will be held April 1-3 in the auditorium of the National Academy of Sciences building at 2100 C St., N.W., Washington, D.C. The lecture is free and open to the public, but a photo I.D. is required to enter the building. For a program and registration visit

REPORTERS who wish to attend please contact the office of News and Public Information, 202-334-2138 or Miriam Glaser Heston, Sackler Colloquium Series, 202-334-1229.

National Academies of Sciences, Engineering, and Medicine

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to